28
Participants
Start Date
November 8, 2018
Primary Completion Date
November 30, 2021
Study Completion Date
April 30, 2022
AMIA with SHARESOURCE Connectivity Platform
The investigators will conduct a randomized, cross-over study in peritoneal dialysis patients in which patients are randomized to either Home Choice Pro (which remains the most widely used Baxter cycler) versus treatment with the Baxter AMIA automated peritoneal dialysis system with SHARESOURCE connectivity.
HomeChoice PRO
Usual care
Home Dialysis Therapies of San Diego, Chula Vista
Home Dialysis Therapies of San Diego, San Diego
Baxter Healthcare Corporation
INDUSTRY
Scripps Health
OTHER
Home Dialysis Therapies of San Diego
UNKNOWN
University of California, San Diego
OTHER